Introduction
Cerebrotendinous xanthomatosis (CTX) is a rare autosomal recessive disorder, due to mutations of the CYP27A1 gene, leading to cholestanol accumulation because of the sterol-27-hydroxylase enzyme deficiency [1] .
Treatment with chenodeoxycholic acid (CDCA) normalizes cholestanol and improves neurophysiological findings.
Several mutations of the CYP27A1 gene are described in different ethnic groups [1] , without genotype-phenotype correlations. We describe two unrelated Sardinian families sharing the same CYP27A1 mutation.
Family 1
A 47-year-old man, born from consanguineous parents from Olbia (northeastern Sardinia), showed cataracts at age 21, progressive walking difficulty since age 24 and severe bipolar disorder at 39. At age 43 tendon xanthomas were identified.
Neurological examination revealed pareto-ataxic gait, hyperactive tendon reflexes, extensor plantar responses, asymmetrical accommodation reflex, mild cognitive impairment, defective attention and short-term memory deficit [Mini-Mental Status Examination (MMSE): 21/30]. Electromyography (EMG) revealed sensorimotor axonal polyneuropathy.
Total cholesterol was 232 mg/dl. Electrocardiogram (ECG) showed signs of a previous myocardial infarction. Echocardiogram, brain and spinal cord magnetic resonance (MRI) were normal.
The patient never received CDCA treatment. Cataracts and tendon xanthomas were also referred in his three brothers, who refused the genetic testing.
Family 2
Parents are first cousins from the Carbonia-Iglesias area (southwestern Sardinia).
The proband, male, was evaluated at 45 years because of progressive walking difficulty. A diagnosis of spastic paraplegia was hypothesized but linkage analysis pointed to CYP27A1 locus. Neurological examination showed paretic gait, hyperactive tendon reflexes, extensor plantar responses, tendon xanthomas, buccal dyskinesia and moderate mental retardation. EMG demonstrated a mild sensorimotor polyneuropathy. Brain MRI showed multiple areas of white matter alterations.
Serum cholestanol was 64.9 mg/l (nv \ 10) and cholesterol 254 mg/dl.
Since age 53 he assumes CDCA 750 mg/day, with xanthomatas reduction but no neurological improvement. 
Electrocardiogram (ECG) Previous myocardial infarction Previous myocardial infarction
Incomplete right bundle branch block
The sister (46 years) reported two elbow neoformations removal (histology not available), progressive walking difficulties since age 34 and cataracts at 44 years. Neurological examination showed paretic gait, extensor plantar responses, long-term attention deficit and a mild cognitive impairment (MMSE 20/30). Brain MRI was normal; spinal MRI showed a non-homogeneous cervical signal. ECG revealed an incomplete right bundle branch block. Serum cholestanol (28.3 mg/l) and total cholesterol (238 mg/dl) were increased.
Since age 45 she assumes CDCA 750 mg/day, with symptomatology stabilization (Table 1 ). The benign significance is also supported by the healthy status of the niece, who resulted as being a compound heterozygote with the p.Arg479Cys and the variant haplotype. Indeed, both she and her brother, who carry only the variant haplotype, have normal cholestanol (4.1 and 3.8 mg/l, respectively).
Molecular analysis

Discussion
The phenotype of our patients is characteristic of CTX.
The frequency of this disorder varies among populations and is higher in inbred ethnic groups [3] . In geographically isolated populations, such as Sardinia, the finding of founder mutations is expected [4] .
The p.Arg479Cys mutation was described either in homozygotes or in compound heterozygotes [2, 5] . The affected Arginine is located next to Cysteine 476 that binds the heme cofactor, thus it is predicted to alter enzyme activity. Transfection of mutant cDNAs into cells results in the synthesis of sterol 27-hydroxylase protein with greatly diminished enzyme activity [2] .
